Categories AlphaGraphs, Health Care
Infographic: Highlights from Gilead Sciences (GILD) Q2 2020 earnings
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the revenue and earnings estimates for the quarter.
GILD shares fell over 2% immediately following the announcement. The stock has gained 11% since the beginning of this year.
CEO Daniel O’Day said, “We are also making important progress with our pipeline. In addition to the critical work of advancing remdesivir, we have continued to strengthen our presence in immuno-oncology. This includes six immuno-oncology agreements this year and the recent FDA approval for TecartusTM in mantle cell lymphoma.”
Prior performance
[irp posts=”67604″]
____
Most Popular
LW Earnings: Key quarterly highlights from Lamb Weston’s Q3 2025 financial results
Lamb Weston Holdings, Inc. (NYSE: LW) reported its third quarter 2025 earnings results today. Net sales increased 4% to $1.52 billion compared to the same period a year ago. Net
CAG Earnings: Highlights of Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported a decrease in net sales and adjusted earnings for the third quarter of 2025. Net sales were
Fastenal Company (FAST) looks poised for a mixed start to FY25
Fastenal Company (NASDAQ: FAST) will report its first-quarter results on April 11, at 6:50 am ET. The company has been investing heavily to expand its digital footprint lately, and it
